Ads by Google
A medication that enhances learning, taken just before an exposure therapy session, may aid cognitive behavior therapy for anxiety disorders.
Shire plc announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANA between boys and girls aged 6 to 12 years with Attention Deficit Hyperactivity Disorder (ADHD).
Children taking ADHD drugs are strongly recommended to pass electrocardiogram heart tests, because the drugs may increase risk for cardiovascular problems.
Shire plc has received approval from FDA for VYVANSE (lisdexamfetamine dimesylate), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults. VYVANSE, introduced in July 2007 for the treatment of ADHD in children aged 6 to 12 years, is now the first and only once-daily prodrug stimulant approved to treat adults with ADHD. In its first eight months of availability, more than one million VYVANSE prescriptions have been filled.
The stimulant drugs, used for ADHD treatment, while not much significant, are important to monitor for children with ADHD and certain heart conditions. This is why ADHD children should receive an electrocardiogram (ECG) to rule out heart abnormalities before beginning ADHD treatment with stimulant drugs.
Young-onset dementia often is caused by neurodegenerative or autoimmune/inflammatory conditions, but only rarely by Alzheimer's disease.
Treating children as early as age six or seven with stimulants for Attention Deficit Hyperactivity Disorder (ADHD) is not likely to increase risk of substance abuse as adults.
People with larger stomachs in their 40s are more likely to have dementia when they reach their 70.
Researchers have discovered perhaps the strongest evidence yet linking variation in a particular gene with anxiety-related traits.
More residents affected by Hurricane Katrina are enduring mental disorders than was initially determined a few months after the storm.
Only about half of children diagnosed with attention-deficit hyperactivity disorder, or ADHD, exhibit the cognitive defects commonly associated with the condition.
New ways of thinking about the ADHD disorder and its treatment are necessary.
Despite more than 30 years of widespread use of lithium to control psychiatric disorders, such as bipolar disorder, scientists have been uncertain about how this drug actually works on a molecular level.
People with manic symptoms and bipolar disorder type II are at significant risk of later developing an alcohol abuse or dependence problem.